Entering text into the input field will update the search result below

Jounce Therapeutics GAAP EPS of -$0.59 misses by $0.27

Mar. 02, 2022 7:06 AM ETJounce Therapeutics, Inc. (JNCE) StockBy: Gaurav Batavia, SA News Editor
  • Jounce Therapeutics press release (NASDAQ:JNCE): Q4 GAAP EPS of -$0.59 misses by $0.27.
  • As of December 31, 2021, cash, cash equivalents and investments were $220.2 million, compared to $213.2 million as of December 31, 2020.
  • FY22 Guidance:
  • Gross cash burn on operating

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Related Stocks

SymbolLast Price% Chg
Jounce Therapeutics, Inc.
NightHawk Biosciences, Inc.
Calithera Biosciences, Inc.
NextCure, Inc.
Broadway Financial Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.